Encompass Health Corp will meet with investors on December 2 and 3, 2025, to discuss financial guidance, reiterating a full-year revenue expectation of $5.905 to $5.955 billion, adjusted EBITDA of $1.235 to $1.255 billion, and earnings per share between $5.22 and $5.37.